Robert Potter
Family Medicine · Noblesville, INNPI 1346334562
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,208 of the $9,422 with a category attached, or 87.1%. It is spread thinly across 38 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,025 and has fallen 97.0% since, to $121 in 2024. Among family medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$1K
- AstraZeneca$760
- Boehringer Ingelheim$487
- Lilly USA, LLC$459
- plus $4K from 32 others
What the payments were for
- Consulting fees$1,20013%
- Food & beverage$8,20887%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $1,465 |
| Biohaven Pharmaceuticals, Inc. | 6 | $1,370 |
| AbbVie(2 entities) | 96 | $1,293 |
| AstraZeneca | 34 | $760 |
| Boehringer Ingelheim | 29 | $487 |
| Lilly USA, LLC | 37 | $459 |
| Pfizer | 30 | $404 |
| Arbor Pharmaceuticals, Inc. | 6 | $382 |
| Amarin Pharma, Inc. | 16 | $371 |
| Merck | 32 | $337 |
| GSK | 7 | $316 |
| Esperion Therapeutics, Inc. | 10 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $219 |
| Medicure Pharma Inc. | 2 | $203 |
| Kowa Pharmaceuticals America, Inc. | 14 | $169 |
| Johnson & Johnson | 10 | $157 |
| Astellas Pharma US Inc | 5 | $92 |
| Ironshore Pharmaceuticals Inc. | 5 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Sanofi Pasteur Inc. | 4 | $71 |
| Abbott | 4 | $64 |
| Adlon Therapeutics L.p. | 3 | $60 |
| Shire North American Group Inc | 4 | $57 |
| Eisai Inc. | 3 | $53 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Novartis | 2 | $28 |
| Almatica Pharma LLC | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 2 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Nalpropion Pharmaceuticals LLC | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bayer | 1 | $17 |
| Mylan Specialty L.p. | 1 | $15 |
| Amgen | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $11 |
| Boston Scientific | 1 | $11 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Clarus Therapeutics Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,325
- VRAYLAR$246
- TRELEGY ELLIPTA$235
- Ozempic$234
- HMG-CoA reductase inhibitor.$191
- BREZTRI AEROSPHERE$125
- NEXLIZET$125
- NEXLETOL$125
- Vascepa$125
- Wegovy$121
- Horizant$119
- RYBELSUS$117
- FARXIGA$107
How this compares
$9,422 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 13 | $262 |
| Ropinirole Hcl | 11 | $193 |
| Mirtazapine | 11 | $179 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $156 |
| Gabapentin | 15 | $153 |
| Famotidine | 11 | $139 |
| Trazodone Hcl | 11 | $114 |
| Lisinopril | 16 | $112 |
| Hydralazine Hcl | 12 | $88 |
| Amlodipine Besylate | 20 | $40 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Noblesville
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.